Lista de obras - Morten Madsen - Dominio Público Uruguay

2-Year Patient-Related Versus Stent-Related Outcomes

artículo científico publicado en 2012

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents

artículo científico publicado en 2012

Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease

scientific article published on 03 April 2019

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.

artículo científico publicado en 2013

Classification and characteristics of on-label and off-label apixaban use in Denmark and Sweden

scientific article published on 16 April 2019

Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial

artículo científico publicado en 2017

Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation

artículo científico publicado en 2018

Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the SORT OUT IV Trial)

Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction

artículo científico publicado en 2011

Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry

artículo científico publicado en 2012

Coronary artery disease and risk of adverse cardiac events and stroke

artículo científico publicado en 2017

Coronary stent implantation and adverse cardiac events after surgery

artículo científico publicado en 2018

Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease

artículo científico publicado en 2019

Diagnostic Performance of In-Procedure Angiography-Derived Quantitative Flow Reserve Compared to Pressure-Derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study

article published in 2018

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

artículo científico publicado en 2014

Dual anti-platelet therapy after coronary drug-eluting stent implantation and surgery-associated major adverse events

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

artículo científico publicado en 2010

Evaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary intervention

scientific article published on 19 October 2016

Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology

artículo científico publicado en 2013

Existing data sources for clinical epidemiology: The Western Denmark Heart Registry.

artículo científico publicado en 2010

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter]

scientific article published on 13 August 2019

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus.

artículo científico publicado en 2019

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

artículo científico

Gastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapy

artículo científico publicado en 2016

Impact of co-morbidity on the risk of first-time myocardial infarction, stroke, or death after single-photon emission computed tomography myocardial perfusion imaging

artículo científico publicado en 2014

Impact of the Charlson Comorbidity Index score on risk prediction by single-photon emission computed tomography myocardial perfusion imaging following myocardial infarction

scientific article published on 25 September 2019

Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia

artículo científico publicado en 2016

Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

artículo científico publicado en 2011

Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment: A Prospective Cohort Study

artículo científico publicado en 2016

Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

artículo científico publicado en 2014

Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark

artículo científico publicado en 2010

Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS)

artículo científico publicado en 2018

Nonsteroidal Antiinflammatory Drug Use and Clinical Outcomes of Community-acquired Pneumonia

scholarly article by Damien Basille et al published July 2018 in American Journal of Respiratory and Critical Care Medicine

Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention

artículo científico publicado en 2010

Outcome of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (a SORT OUT III Substudy)

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

artículo científico publicado en 2014

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry

artículo científico publicado en 2010

Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment

artículo científico publicado en 2017

Predicting stroke in patients without atrial fibrillation

scientific article published on 18 March 2019

Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial

artículo científico

Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavia

artículo científico publicado en 2018

Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).

artículo científico

Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography study

artículo científico publicado en 2017

Rational and design of the European randomized Optical Coherence Tomography Optimized Bifurcation Event Reduction Trial (OCTOBER)

artículo científico publicado en 2018

Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation

artículo científico publicado en 2016

Ten-Year Outcomes of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stents in Patients With Versus Without Diabetes Mellitus (SORT OUT III)

scientific article published on 07 November 2019

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

artículo científico publicado en 2019

The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation

scholarly article by Per Thayssen et al published September 2012 in EuroIntervention

Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial

artículo científico publicado en 2014

Validation of the European Society of Cardiology and European Society of Anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation

artículo científico publicado en 2019

Variation in use of peroperative inotropic support therapy in cardiac surgery: time for reflection?

artículo científico publicado en 2011

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

artículo científico publicado en 2015

Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy

artículo científico publicado en 2012

Lista de obras de Morten Madsen

2-Year Patient-Related Versus Stent-Related Outcomes

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents

Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.

Classification and characteristics of on-label and off-label apixaban use in Denmark and Sweden

Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial

Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation

Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the SORT OUT IV Trial)

Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction

Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry

Coronary artery disease and risk of adverse cardiac events and stroke

Coronary stent implantation and adverse cardiac events after surgery

Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease

Diagnostic Performance of In-Procedure Angiography-Derived Quantitative Flow Reserve Compared to Pressure-Derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Dual anti-platelet therapy after coronary drug-eluting stent implantation and surgery-associated major adverse events

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

Evaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary intervention

Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology

Existing data sources for clinical epidemiology: The Western Denmark Heart Registry.

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter]

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus.

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

Gastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapy

Impact of co-morbidity on the risk of first-time myocardial infarction, stroke, or death after single-photon emission computed tomography myocardial perfusion imaging

Impact of the Charlson Comorbidity Index score on risk prediction by single-photon emission computed tomography myocardial perfusion imaging following myocardial infarction

Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia

Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment: A Prospective Cohort Study

Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark

Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS)

Nonsteroidal Antiinflammatory Drug Use and Clinical Outcomes of Community-acquired Pneumonia

Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention

Outcome of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (a SORT OUT III Substudy)

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry

Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment

Predicting stroke in patients without atrial fibrillation

Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial

Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavia

Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).

Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography study

Rational and design of the European randomized Optical Coherence Tomography Optimized Bifurcation Event Reduction Trial (OCTOBER)

Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation

Ten-Year Outcomes of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stents in Patients With Versus Without Diabetes Mellitus (SORT OUT III)

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation

Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial

Validation of the European Society of Cardiology and European Society of Anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation

Variation in use of peroperative inotropic support therapy in cardiac surgery: time for reflection?

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy